Invitrogen Corporation Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Apr 22 Calls Today's Calls

Call Details Invitrogen Corporation Earnings Conference Call (Q1 2008) Tue, Apr 22, 2008, 4:30 pm Eastern Listen to the archived event audio About Invitrogen Corporation (NasdaqGS:IVGN) Invitrogen Corporation engages in the development, manufacture, and marketing of research tools in reagent, kit, and applications forms for the life sciences research, drug discovery, and diagnostics customers, as well as biological products manufacturers. It operates in two segments, BioDiscovery and Cell Systems. The BioDiscovery segment provides molecular biology, cell biology, and drug discovery product lines. The Molecular biology product line includes research tools used in reagent and kit forms that simplify and improve gene acquisition, gene cloning, gene expression, and gene analysis techniques. It also offers various enzymes, nucleic acids, other biochemicals, and reagents; and software that enables analysis and interpretation of genomic, proteomic, and other biomolecular data for application in pharmaceutical, therapeutic, and diagnostic development. In addition, this segment provides antibodies and proteins, and magnetic beads used for biological separation. The Cell Systems segment offers sera, growth factors, cell, and tissue culture media used in life sciences research, as well as in the production of bio-pharmaceuticals and other materials made through cultured cells. It also offers services, which include the creation of stable cell lines and the optimization of production processes used for the production of therapeutic drugs. In addition, this segment manufactures biologics on behalf of its clients for use in clinical trials and for the worldwide commercial market. The company offers its products to the life sciences research market and the biopharmaceutical production market directly, and through distributors or agents in approximately 70 countries. It has a collaboration agreement with BMG LABTECH, Inc. Invitrogen was founded in 1987 and is based in Carlsbad, California. More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials | Analyst Ratings